GLOW
A three-compound regenerative research blend combining BPC-157, GHK-Cu and TB-500 in a single lyophilized vial.
01At a Glance
| Compound | GLOW |
| Classification | Regenerative research compound |
| Constituents | BPC-157 10 mg — 1,419.5 g/mol GHK-Cu 50 mg — 404.92 g/mol TB-500 10 mg — 4,963.4 g/mol |
| Molecular weight | Blend — see constituents |
| Sequence / Form | BPC-157 10 mg · GHK-Cu 50 mg · TB-500 10 mg |
| Purity | ≥98% HPLC, identity verified by mass spectrometry |
| Documentation | Batch-specific Certificate of Analysis available |
| Appearance | White lyophilized powder |
| Storage | Store sealed at 2–8°C. Long-term storage per certificate guidance. |
| Use | Research Use Only. Not for human or veterinary use. |
02Mechanism of Action
GLOW co-formulates three compounds whose published research converges on tissue-repair and extracellular-matrix signaling, studied individually in wound-healing and angiogenesis models.
BPC-157 is investigated for VEGF-pathway and fibroblast-migration effects; GHK-Cu for copper-dependent modulation of collagen and metalloproteinase gene expression; TB-500 for actin sequestration and cell-motility dynamics. The blend exists so all three can be introduced to a single assay preparation rather than reconstituted separately.
No published literature characterises the three-compound combination itself. Research framing for GLOW rests on the individual constituent literature.
Research framing only · No human-use claims
03Research Context
- Combined-compound wound-healing and repair assays
- Angiogenesis and VEGF-pathway models
- Collagen synthesis and matrix-remodeling studies
- Actin-dynamics and cell-migration research
04Quality & Verification
Ethos Bio presents compound information with an emphasis on identity verification, purity analysis, certificate access, and storage guidance. Product-specific documentation is available through the certificate page where applicable. Cold-chain shipping is available where required, and inventory is held under refrigerated conditions at our fulfillment center with temperature-logging protocols in place.
05FAQ
What is in GLOW?
GLOW is a single lyophilized vial containing BPC-157 10 mg, GHK-Cu 50 mg and TB-500 10 mg — 70 mg total peptide content. Each constituent is verified for identity and purity.
Why are these three compounds combined?
All three are studied in tissue-repair and extracellular-matrix research, but by different mechanisms. Co-formulation allows a single reconstitution rather than three, which is why the blend is used in combined-compound assay work.
Is there research on the GLOW combination itself?
No. Published research covers the three constituents individually. Ethos Bio makes no claims about the combination and provides constituent-level documentation only.
How should GLOW be stored?
GLOW ships lyophilized and should be handled per standard research-peptide practice — kept cold, protected from light and moisture, and reconstituted only for laboratory use. Cold-chain handling is used where required. For research use only.
Is GLOW approved for human use?
No. GLOW is sold strictly for laboratory research use only and is not a drug or supplement. It is not approved for human or veterinary use or consumption.
How is GLOW tested at Ethos Bio?
Every lot is independently verified by Kovera Labs on a third-party analytical panel — RP-HPLC purity and HPLC-MS identity confirmation — and a lot-specific certificate of analysis issued to Ethos Bio ships with the vial. See How We Test for the full methodology.